Breast cancer patients frequently experience pain as a symptom, which has been the subject of longitudinal studies and systematic reviews investigating its prevalence, severity, and long-term course post-treatment as evidenced by [1], [2], [3], and [4]. Measurements of pain levels in these patients, such as those using the MPQ-VAS scale, demonstrate how this symptom evolves over time following primary treatment [5] and [6].